Kuniyoshi Mizumachi, Kenichi Ogiwara, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami. Factor X consumption attenuates the coagulation effect of emicizumab: a case of severe hemophilia A treated with emicizumab and factor VIII-bypassing agents. International journal of hematology. 2025. 121. 1. 126-130
Masahiro Takeyama, Kana Sasai, Yasuo Miyaguchi, Kenichi Ogiwara, Shoko Furukawa, Naruto Shimonishi, Yuto Nakajima, Hitoshi Ueda, Keiji Nogami. The in vitro cross-reactivity and blood coagulation potential of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A. International journal of hematology. 2025. 121. 1. 45-55
Naruto Shimonishi, Kenichi Ogiwara, Kengo Onishi, Toshiki Kawabe, Tomohisa Nishio, Keiji Nogami. A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples. International journal of hematology. 2024
Naruto Shimonishi, Eriko Morishita, Kenichi Ogiwara, Keiko Maruyama, Junko Yoshida, Kyoji Horie, Keiji Nogami. A novel factor V compound heterozygous mutation associated with thrombosis (Y1961C; FV-Kanazawa, together with 1982_1983del). Journal of thrombosis and haemostasis : JTH. 2024
Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Midori Shima, Keiji Nogami. Escaping Ability of Human-Porcine Hybrid Factor VIII from Anti-Factor VIII Inhibitors with an A2 or C2 Epitope. BLOOD. 2022. 140. 8430-8431
